GLPBio

Lipoxygenase

Read More about this category

Lipoxygenases (LOXs) are dioxygenases that catalyze the formation of corresponding hydroperoxides from polyunsaturated fatty acids such as linoleic acid and arachidonic acid. Thre are six LOX isoforms have been found in the humans and mice. 5-Lipoxygenase (5-LOX) is a distinct isoform playing an important role in asthma and inflammation. 5-LOX causes the constriction of bronchioles in response to cysteinyl leukotrienes such as LTC4, thus leading to asthma. 5-LOX also induces neutrophilic inflammation by its recruitment in response to LTB4. 12-Lipoxygenase (12-LOX) is an isoform expressed in epithelial cells and myeloid cells including platelets. 12-LOX can be found in the epithelial cells of the skin. 12-LOX is a potential target for novel anti-platelet therapeutics.15-Lipoxygenase (15-LOX) is expressed in epithelial cells and leukocytes, has different substrate specificity in the humans and mice.15-LOX-1 is a target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells.

Products Related to Lipoxygenase(264)

  • GC10451 structure
    GC10451U-73122
    CAS: 112648-68-7
    Purity: >98.00%

    U-73122 es un inhibidor potente y selectivo de la fosfolipasa C (PLC) con un valor de IC50 de aproximadamente 1-2.1 μM. También inhibe la 5-lipoxigenasa (5-LO).

  • GC10821 structure
    GC1082111-keto-β-Boswellic Acid
    CAS: 17019-92-0
    Purity: >99.50%

    El Ácido 11-Keto-beta-boswélico (11-Keto-β-Ácido boswélico) es un Ácido triterpénico pentacÍclico de la resina de oleogoma de la corteza del Árbol serrado de Boswellia, conocido popularmente como Incienso de la India. El Ácido 11-ceto-beta-boswélico tiene actividad antiinflamatoria que se debe principalmente a la inhibiciÓn de la 5-lipoxigenasa (5-LOX) y la posterior activaciÓn de los leucotrienos y el factor nuclear kappa B (NF-κB) y la generaciÓn del factor de necrosis tumoral alfa producciÓn.

  • GC12661 structure
    GC12661Indirubin-3'-oxime
    CAS: 160807-49-8
    Purity: >99.00%

    La indirrubina-3'-oxima es un potente GSK-3β inhibidor e inhibe débilmente la 5-lipoxigenasa, con IC50 de 22 nM y 7,8-10 μM, respectivamente; La indirrubina-3'-oxima también muestra actividades inhibitorias frente a CDK5/p25 y CDK1/ciclina B, con IC50 de 100 y 180 nM.

  • GC14435 structure
    GC14435Zileuton sodium
    CAS: 118569-21-4
    Purity: >98%

    El zileutÓn sÓdico (A 64077 sÓdico) es un inhibidor potente y selectivo de la 5-lipoxigenasa, que exhibe actividades inflamatorias.

  • GC14751 structure
    GC14751Malotilate
    CAS: 59937-28-9
    Purity: >99.50%

    El malotilato (NKK 105), un agente hepatotrÓpico activo por vÍa oral y una sustancia antifibrÓtica, inhibe selectivamente la 5-lipoxigenasa (5-LOX) (IC50 = 4,7 μM). El malotilato previene el desarrollo de lesiÓn hepatocÍtica en la hepatitis por alcohol-pirazol al disminuir los niveles de acetaldehÍdo hepÁtico y prevenir la retenciÓn de transferrina en los hepatocitos.

  • GC14847 structure
    GC14847Psoralidin
    CAS: 18642-23-4
    Purity: >98.00%

    La psoralidina es un inhibidor dual de COX-2 y 5-LOX, regula la inflamaciÓn pulmonar inducida por radiaciÓn ionizante (IR). Propiedades anticancerÍgenas, antibacterianas y antiinflamatorias. La psoralidina regula significativamente a la baja la seÑalizaciÓn de NOTCH1. La psoralidina también induce en gran medida la generaciÓn de ROS.

  • GC16014 structure
    GC16014Zileuton
    CAS: 111406-87-2
    Purity: >99.00%

    Zileuton, un benzotiofeno N-hydroxyurea, es un inhibidor oral de la 5-Lipoxygenase

  • GC18089 structure
    GC18089Nordihydroguaiaretic acid
    CAS: 500-38-9
    Purity: >97.00%

    Nordihydroguaiaretic acid is a potent 5-lipoxygenase (5-LOX) inhibitor with an IC 50 value of 8μM.

  • GC18480 structure
    GC18480CAY10649
    CAS: 1272519-89-7
    Purity: >98%

    5-Lipoxygenase (5-LO) catalyzes the biosynthesis of leukotrienes, which are involved in a variety of inflammatory responses, including neutrophil chemotaxis, vascular permeability, and smooth muscle contraction.

  • GC18552 structure
    GC18552Lipoxin A4
    CAS: 89663-86-5
    Purity: >95.00%

    Un ácido graso trihidroxilado que contiene un tetraeno conjugado.

  • GC18680 structure
    GC18680Lipoxin A4 methyl ester
    CAS: 97643-35-1
    Purity: >95.00%

    Lipoxin A4 methyl ester (LXA4 methyl ester) is a more lipid soluble, prodrug formulation of the transcellular metabolite LXA4.

  • GC18681 structure
    GC18681Lipoxin B4
    CAS: 98049-69-5
    Purity: >95.00%

    Lipoxin B4 (LXB4) is a positional isomer of LXA4 produced by the metabolism of 15-HETE or 15(S)-HpETE by human leukocytes.

  • GC18688 structure
    GC18688CAY10589
    CAS: 1077626-52-8
    Purity: >98%

    Microsomal Prostaglandin E2 Synthase-1 (mPGES-1), with cyclooxygenase-2 (COX-2), synthesizes PGE2, which is directly involved in signaling during inflammation, fever and pain.

  • GC18728 structure
    GC18728CJ-13610
    CAS: 179420-17-8
    Purity: >98%

    CJ-13610, un inhibidor de 5-LO de tipo no redox, suprime de forma dependiente de la dosis la formación del producto 5-LO en PMNL estimulado con ionóforo A23187 en ausencia de AA exógeno con una IC50 de aproximadamente 70 nM.

  • GC18835 structure
    GC18835Leukotriene A4 methyl ester
    CAS: 73466-12-3
    Purity: >97.00%

    Leukotriene A4 (LTA4) is synthesized in mast cells, eosinophils, and neutrophils from arachidonic acid by 5-lipoxygenase (5-LO), which exhibits both lipoxygenase and LTA4 synthase activities.

  • GC18845 structure
    GC18845Leukotriene F4
    CAS: 83851-42-7
    Purity: >97.00%

    El leucotrieno F4 (LTF4), es un lÍpido que pertenece a la familia de los cisteinil leucotrienos (CysTL).

  • GC18877 structure
    GC18877CAY10606
    CAS: 1159576-98-3
    Purity: >98%

    5-Lipoxygenase (5-LO) initiates the synthesis of leukotrienes (LTs) from arachidonic acid, primarily in certain leukocyte populations.

  • GC19460 structure
    GC194609(S)-HODE
    CAS: 73543-67-6
    Purity: >98.00%

    9(S)-HODE is produced by the lipoxygenation of linoleic acid in both plants and animals.

  • GC19462 structure
    GC1946213(R)-HODE
    CAS: 10219-69-9
    Purity: >98.00%

    13(R)-HODE is the opposite enantiomer of the 13(S)-HODE produced when linoleic acid is incubated with soybean lipoxygenase.

  • GC19463 structure
    GC1946313(S)-HODE
    CAS: 29623-28-7
    Purity: >98.00%

    13(S)-HODE (13(S)-HODE), el producto del metabolismo de la 15-lipoxigenasa (15-LOX) del Ácido linoleico, funciona como ligando endÓgeno para activar PPARγ.

  • GC19474 structure
    GC1947413(S)-HpODE
    CAS: 33964-75-9
    Purity: >95.00%

    13(S)-HpODE is produced by the oxidation of linoleic acid by lipoxygenase-1 (LO-1) in many plants including soybean, flaxseed, apples, and tea leaves,1,2 and by 15-LO in mammals.

  • GC19933 structure
    GC19933Leukotriene B4
    CAS: 71160-24-2
    Purity: >95.00%

    El leucotrieno B4 (LTB4) es conocido como uno de los quimioatrayentes y activadores de leucocitos mÁs potentes y estÁ implicado en enfermedades inflamatorias.

  • GC26233 structure
    GC26233Docosahexaenoic Acid-d5
    CAS: 1197205-71-2
    Purity: >99.00%

    Docosahexaenoic acid-d5 (DHA-d5) is intended for use as an internal standard for the quantification of DHA (Item No. 90310) by GC- or LC-MS.

  • GC30027 structure
    GC30027S-(+)-Marmesin ((+)-Marmesin)
    CAS: 13849-08-6
    Purity: >98.00%

    S-(+)-Marmesin ((+)-Marmesin) es una cumarina natural que exhibe actividad inhibitoria dual COX-2/5-LOX.